, Tracking Stock Market Picks
Enter Symbol:
Becton, Dickinson And Company (BDX) [hlAlert]

Mkt Perform
up 20.69 %

Becton, Dickinson And Company (BDX) downgraded to Mkt Perform by Leerink Swann

Posted on: Friday,  Aug 3, 2012  8:25 AM ET by Leerink Swann

Leerink Swann rated Mkt Perform Becton, Dickinson And Company (NYSE: BDX) on 08/03/2012. Previously Leerink Swann rated Outperform Becton, Dickinson And Company
(NYSE: BDX) on 12/02/2008., when the stock price was $62.30. Since then, Becton, Dickinson And Company has gained 20.69% as of 08/03/2012's recent price of $75.19.
If you would have followed the previous Leerink Swann 's recommendation on BDX, you would have gained 20.69% of your investment in 1340 days.

Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/3/2012 8:25 AM Hold
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD up  0.62 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/2/2008 8:25 AM Buy
62.30 76.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy